New York, NY -- (SBWIRE) -- 01/06/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: NII Holdings Inc(NASDAQ:NIHD), The Wendy's Co(NASDAQ:WEN), Athersys, Inc.(NASDAQ:ATHX), Mast Therapeutics Inc(NYSEMKT:MSTX)
NII Holdings Inc(NASDAQ:NIHD) reported gain 0.76% and closed at $2.65 with the total traded volume of 3.56M shares. Its market capitalization is $456.96M. The stock has a 52-week high price of 9.82 and its 52-week low was recorded at $1.90.
NII Holdings, Inc. (NII Holdings) is a holding company for the operations of Nextel Communications, Inc. in selected International markets.
What NIHD Charts Are Signaling for Traders? Find Out Here
The Wendy's Co(NASDAQ:WEN) loss -1.14% and ended at $8.68.The total traded volume was 3.51M shares and market capitalization arrived at $3.40B. The stock has a 52-week high price of $9.51 and its 52-week low was recorded at $4.70, while during last trade its minimum price was $8.61 and it gained the highest price of $8.84.
The Wendy’s Company is a quick-service restaurant company in the hamburger sandwich segment. Wendy’s is primarily engaged in the business of operating, developing and franchising a system of distinctive quick-service restaurants serving food. At December 30, 2012, there were 6,186 Wendy’s restaurants in operation in North America. Of these restaurants, 1,427 were operated by Wendy’s and 4,759 by a total of 439 franchisees.
Is WEN Buy After The Recent Price Movement? Find Out Here
Athersys, Inc.(NASDAQ:ATHX)’s reported the loss -2.71% to close at $2.87 with the overall traded volume of 3.45M shares. Its market capitalization on last close reached to $202.46 million. Its intraday-low price was $2.51 and its hit its day's highest price at $2.99.
Athersys Inc. is a biopharmaceutical company engaged in the field of regenerative medicine. During the year ended December 31, 2011 the Company is developing its platform product, MultiStem, a allogeneic stem cell product that has been evaluated in two completed Phase I clinical trials and as of December 31, 2011, is being evaluated in two ongoing Phase II clinical trials.
Should ATHX a Buy or Sell Now? Find Out Here
Mast Therapeutics Inc(NYSEMKT:MSTX) increase 5.78% settle at $0.500. Its total traded volume during last trading session was 3.35M shares. The overall market worth of this company is about $51.33M. The 52 week range of the stock remained $0.40- $0.81, while its day's lowest price was $0.47 and its hit its day's highest price at $0.51.
Mast Therapeutics, Inc., formerly ADVENTRX Pharmaceuticals, Inc., is a development-stage company biopharmaceutical company focused on developing product candidates.
What MSTX Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)